These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7399665)

  • 1. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.
    Ohishi I; Sakaguchi G
    Infect Immun; 1980 May; 28(2):303-9. PubMed ID: 7399665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral toxicities of Clostridium botulinum type A and B toxins from different strains.
    Ohishi I
    Infect Immun; 1984 Feb; 43(2):487-90. PubMed ID: 6693168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes.
    Sugii S; Ohishi I; Sakaguchi G
    Infect Immun; 1977 Jun; 16(3):910-4. PubMed ID: 19355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicities of Clostridium botulinum type C toxins of different molecular sizes in geese.
    Ohishi I; Hayashi K; Sakaguchi G; Tokuchi M
    Infect Immun; 1981 Aug; 33(2):623-4. PubMed ID: 7275321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral toxicities of Clostridium botulinum toxins in response to molecular size.
    Ohishi I; Sugii S; Sakaguchi G
    Infect Immun; 1977 Apr; 16(1):107-9. PubMed ID: 326664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of Clostridium botuliunum type F progenitor toxin.
    Oishi I; Sakaguchi G
    Appl Microbiol; 1974 Dec; 28(6):923-8. PubMed ID: 4615636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular construction of Clostridium botulinum type F progenitor toxin.
    Ohishi I; Sakaguchi G
    Appl Microbiol; 1975 Apr; 29(4):444-7. PubMed ID: 235882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal absorption of botulinum toxins of different molecular sizes in rats.
    Sugii S; Ohishi I; Sakaguchi G
    Infect Immun; 1977 Sep; 17(3):491-6. PubMed ID: 903173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of a toxic component of Clostridium botulinum types C and D by trypsin.
    Eklund MW; Poysky FT
    Appl Microbiol; 1972 Jul; 24(1):108-13. PubMed ID: 4560464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid method for purification of Clostridium botulinum type C neurotoxin by high performance liquid chromatography (HPLC).
    Matsuda M; Ozutsumi K; Du PY; Sugimoto N
    Eur J Epidemiol; 1986 Dec; 2(4):265-71. PubMed ID: 3542554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Apr; 268(2):220-7. PubMed ID: 3293334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inactivation of Clostridium botulinum toxins types B, C and E by digestive juices of man and ducks.
    Notermans S; Kozaki S; Dufrenne J; van Schothorst M
    Jpn J Med Sci Biol; 1980 Oct; 33(5):255-61. PubMed ID: 7300037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.
    Miyata K; Sagane Y; Inui K; Miyashita S; Suzuki T; Oguma K; Ohyama T; Niwa K; Watanabe T
    Protein J; 2012 Jun; 31(5):387-92. PubMed ID: 22565346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro reconstitution of the Clostridium botulinum type D progenitor toxin.
    Kouguchi H; Watanabe T; Sagane Y; Sunagawa H; Ohyama T
    J Biol Chem; 2002 Jan; 277(4):2650-6. PubMed ID: 11713244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.